FDA Approves Corlanor® (ivabradine) To Reduce The Risk Of Hospitalization For Worsening Heart Failure In Patients With Chronic Heart Failure
Corlanor is the First New Chronic Heart Failure Medicine Approved by the FDA in Nearly a Decade
Amgen - Investors - RSS Content
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.